U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090092
Company: HETERO LABS LTD III
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ZIDOVUDINE ZIDOVUDINE 300MG TABLET;ORAL Prescription AB No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/25/2008 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/090092s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/10/2020 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

02/10/2020 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

02/10/2020 SUPPL-6 Labeling-Package Insert

Label is not available on this site.

02/25/2010 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

03/05/2009 SUPPL-1 Labeling

Label is not available on this site.

ZIDOVUDINE

TABLET;ORAL; 300MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ZIDOVUDINE ZIDOVUDINE 300MG TABLET;ORAL Prescription No AB 077267 AUROBINDO
ZIDOVUDINE ZIDOVUDINE 300MG TABLET;ORAL Prescription No AB 090561 CIPLA
ZIDOVUDINE ZIDOVUDINE 300MG TABLET;ORAL Prescription No AB 090092 HETERO LABS LTD III
ZIDOVUDINE ZIDOVUDINE 300MG TABLET;ORAL Prescription No AB 078922 MYLAN PHARMS INC
Back to Top